Director Dealings
Updated : 12:38
30 November 2021
ECO Animal Health Group PLC
("ECO" or "the Company")
Directors Dealings
ECO Animal Health Group plc was notified today that on 30 November 2021 the following Director purchases of ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") were made.
Marc Loomes, Chief Executive Officer of the Company, purchased 33,244 Ordinary Shares at a price of 150.40 pence per Ordinary Share. As a result of this transaction, Marc Loomes' total shareholding in the Company comprises 33,244 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital.
Christopher Wilks, Chief Financial Officer of the Company, purchased 16,595 Ordinary Shares at a price of 150.64 pence per Ordinary Share. As a result of this transaction, Christopher Wilks' total shareholding in the Company comprises 24,095 Ordinary Shares, representing approximately 0.04 per cent. of the Company's issued share capital.
Contacts:
ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO)
|
|
IFC Advisory Graham Herring Zach Cohen
| 020 3934 6630
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas
| 020 7496 3000 |
Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden
| 020 7418 8900 |
Equity Development Hannah Crowe Matt Evans
| 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products
PDMR Notification
The notification below is made in accordance with the requirements of MAR
Acquisition of Ordinary Shares
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Marc Loomes
| ||||
2. | Reason for the notification | |||||
a. | Position/status | Chief Executive Officer
| ||||
b. | Initial notification /Amendment
| Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Eco Animal Health Group Plc | ||||
b. | LEI | 2138009XN9DJ3YP70B55 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 5p each.
GB0032036807
| ||||
b. | Nature of the transaction | Acquisition of Ordinary Shares | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information Aggregated volume Price
|
n/a
| ||||
e. | Date of the transaction | 30 November 2021 | ||||
f. | Place of the transaction | London Stock Exchange, AIM Market (XLON)
|
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Christopher Wilks
| ||||
2. | Reason for the notification | |||||
a. | Position/status | Chief Financial Officer
| ||||
b. | Initial notification /Amendment
| Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Eco Animal Health Group Plc | ||||
b. | LEI | 2138009XN9DJ3YP70B55 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 5p each.
GB0032036807
| ||||
b. | Nature of the transaction | Acquisition of Ordinary Shares | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information Aggregated volume Price
|
n/a
| ||||
e. | Date of the transaction | 30 November 2021 | ||||
f. | Place of the transaction | London Stock Exchange, AIM Market (XLON)
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.